Postpolio syndrome--response to deprenyl (selegiline)
- PMID: 8407144
- DOI: 10.3109/00207459309000603
Postpolio syndrome--response to deprenyl (selegiline)
Abstract
Two patients with postpolio syndrome are presented. The first case developed mild Parkinson's syndrome, for which she was treated with a levodopa/carbidopa combination followed by the institution of deprenyl. An unexpected improvement in the symptoms of postpolio syndrome was noted. The second patient who was unaffected by Parkinson's syndrome was started on deprenyl alone and reported a similar improvement in symptomatology.
Similar articles
-
Early combination of selegiline and low-dose levodopa as initial symptomatic therapy in Parkinson's disease. Experience in 26 patients receiving combined therapy for 26 months.Arch Neurol. 1991 Jan;48(1):31-4. doi: 10.1001/archneur.1991.00530130039017. Arch Neurol. 1991. PMID: 1898848
-
The effect of deprenyl and levodopa on the progression of Parkinson's disease.Ann Neurol. 1995 Nov;38(5):771-7. doi: 10.1002/ana.410380512. Ann Neurol. 1995. PMID: 7486869 Clinical Trial.
-
Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.Drug Saf. 1998 Jul;19(1):11-22. doi: 10.2165/00002018-199819010-00002. Drug Saf. 1998. PMID: 9673855 Review.
-
Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease.Neurology. 1991 Jun;41(6):859-61. doi: 10.1212/wnl.41.6.859. Neurology. 1991. PMID: 1904564
-
Treatment of Parkinson's disease.Curr Opin Neurol Neurosurg. 1993 Jun;6(3):339-43. Curr Opin Neurol Neurosurg. 1993. PMID: 8507903 Review.
Cited by
-
Treatment for postpolio syndrome.Cochrane Database Syst Rev. 2015 May 18;2015(5):CD007818. doi: 10.1002/14651858.CD007818.pub3. Cochrane Database Syst Rev. 2015. PMID: 25984923 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical